Cargando…

The concentration of interleukin-33 in heart failure with reduced ejection fraction

OBJECTIVE: Despite several improvements in the management of heart failure (HF), it is still an incurable and a progressive disease. Several trials demonstrated that the process of inflammation may be responsible for initiation and progression of HF. The aim of the present study was to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anna Segiet, Oliwia, Romuk, Ewa, Nowalany-Kozielska, Ewa, Wojciechowska, Celina, Piecuch, Adam, Wojnicz, Romuald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683223/ https://www.ncbi.nlm.nih.gov/pubmed/31142723 http://dx.doi.org/10.14744/AnatolJCardiol.2019.64614

Ejemplares similares

por: Segiet, Oliwia Anna, et al.
Publicado: (2019)

Role of interleukins in heart failure with reduced ejection fraction
por: Segiet, Oliwia Anna, et al.
Publicado: (2019)

Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Oxidative Stress Markers and C-Reactive Protein Are Related to Severity of Heart Failure in Patients with Dilated Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2014)

Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy
por: Romuk, Ewa, et al.
Publicado: (2019)

Notch and its oncogenic activity in human malignancies
por: Brzozowa-Zasada, Marlena, et al.
Publicado: (2017)

Handheld Capillary Blood Lactate Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and Heart Failure Occurrence during Long-Term Follow-Up
por: Kubiak, Grzegorz M., et al.
Publicado: (2016)

Methodological problems in the measurement of interleukin-33 concentrations in patients with heart failure with a reduced ejection fraction
por: Keskin, Berhan, et al.
Publicado: (2019)

Immunohistochemical assessment of mitochondrial superoxide dismutase (MnSOD) in colorectal premalignant and malignant lesions
por: Piecuch, Adam, et al.
Publicado: (2016)

Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome
por: Kawecki, Damian, et al.
Publicado: (2015)

Ceruloplasmin as Redox Marker Related to Heart Failure Severity
por: Lazar-Poloczek, Elżbieta, et al.
Publicado: (2021)

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)

Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients
por: Romuk, Ewa, et al.
Publicado: (2020)

Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure
por: Romuk, Ewa, et al.
Publicado: (2019)

The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress—Role of New Drugs, Flozins
por: Bodnar, Patryk, et al.
Publicado: (2023)

Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction
por: Rossitto, Giacomo, et al.
Publicado: (2020)

Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction
por: Edmonston, Daniel, et al.
Publicado: (2023)

The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases
por: Kolaszko, Agnieszka, et al.
Publicado: (2018)

Oxidative stress and angiogenesis in primary hyperparathyroidism
por: Deska, Mariusz, et al.
Publicado: (2016)

Corrigendum to “The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases”
por: Kolaszko, Agnieszka, et al.
Publicado: (2018)

Comparison of Oxidative Stress Parameters in Heart Failure Patients Depending on Ischaemic or Nonischaemic Aetiology
por: Romuk, Ewa, et al.
Publicado: (2019)

The prognostic value of altitude in patients with heart failure with reduced ejection fraction
por: Kaya, Ahmet, et al.
Publicado: (2019)

Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction
por: Lee, Chan Joo, et al.
Publicado: (2020)

Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction
por: Isaza, Nicolas, et al.
Publicado: (2021)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Respiratory support in acute heart failure with preserved vs reduced ejection fraction
por: Metkus, Thomas S., et al.
Publicado: (2019)

Vaccine‐preventable disease hospitalized patients with heart failure with reduced ejection fraction
por: Del Cid Fratti, Juan, et al.
Publicado: (2022)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Relationship Between Urinary Angiotensinogen and Mortality in Patients with Heart Failure with Reduced Ejection Fraction
por: Örsçelik, Özcan, et al.
Publicado: (2023)

Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy
por: Wojciechowska, Celina, et al.
Publicado: (2021)

Association of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes
por: Li, Junfeng, et al.
Publicado: (2016)

Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction
por: Kitai, Takeshi, et al.
Publicado: (2020)

Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
por: Frisk, Michael, et al.
Publicado: (2021)

Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults
por: Zhao, Li, et al.
Publicado: (2022)

Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction
por: Scandalis, Lina, et al.
Publicado: (2023)

Quantitative myocardial blush score (QuBE) allows the prediction of heart failure development in long-term follow-up in patients with ST-segment elevation myocardial infarction: Proof of concept study
por: Tomasik, Andrzej, et al.
Publicado: (2019)

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
por: Chia, Yook Chin, et al.
Publicado: (2021)

Heart Failure with Preserved Ejection Fraction—a Concise Review
por: Adamczak, Daria M., et al.
Publicado: (2020)

Gender disparities in heart failure with mid-range and preserved ejection fraction: Results from APOLLON study
por: Özlek, Bülent, et al.
Publicado: (2019)

Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis
por: Halabi, Amera, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bj4oqdlvofhvo36m1ns7golh0m